**Core Concept**
Anti-Topoisomerase I (Scl-70) and anti-RNA polymerase III are specific autoantibodies associated with various autoimmune diseases, particularly systemic sclerosis (scleroderma). These autoantibodies are used as diagnostic markers to help differentiate between different autoimmune conditions.

**Why the Correct Answer is Right**
Anti-Topoisomerase I (Scl-70) and anti-RNA polymerase III are commonly found in patients with diffuse systemic sclerosis, a subtype characterized by rapid progression and extensive skin involvement. The presence of these autoantibodies is often associated with more severe disease manifestations, including pulmonary fibrosis and renal crisis. Topoisomerase I is a nuclear enzyme involved in DNA replication and repair, while RNA polymerase III is a nuclear enzyme responsible for transcription of certain genes.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because anti-centromere antibodies are typically associated with limited systemic sclerosis, a subtype characterized by slow progression and limited skin involvement.
**Option B:** This option is incorrect because anti-Sm and anti-RNP antibodies are commonly found in systemic lupus erythematosus (SLE), a different autoimmune disease.
**Option C:** This option is incorrect because anti-SSA/Ro and anti-SSB/La antibodies are associated with Sjögren's syndrome, another autoimmune condition.

**Clinical Pearl / High-Yield Fact**
When encountering a patient with systemic sclerosis, remember to check for the presence of anti-Topoisomerase I (Scl-70) and anti-RNA polymerase III antibodies to help differentiate between the diffuse and limited subtypes and to predict disease severity.

**Correct Answer: D**